Xiaorong Fu

5.1k total citations · 2 hit papers
59 papers, 3.7k citations indexed

About

Xiaorong Fu is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Xiaorong Fu has authored 59 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 17 papers in Physiology and 13 papers in Epidemiology. Recurrent topics in Xiaorong Fu's work include Diet and metabolism studies (14 papers), Mitochondrial Function and Pathology (13 papers) and Liver Disease Diagnosis and Treatment (13 papers). Xiaorong Fu is often cited by papers focused on Diet and metabolism studies (14 papers), Mitochondrial Function and Pathology (13 papers) and Liver Disease Diagnosis and Treatment (13 papers). Xiaorong Fu collaborates with scholars based in United States, China and South Korea. Xiaorong Fu's co-authors include Shawn C. Burgess, Alexander Halim, Guanbin Song, Ge Liu, Yang Ju, Qing Luo, Jeffrey D. Browning, Santhosh Satapati, Blanka Kucejová and Stanisław Deja and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Xiaorong Fu

57 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mesenchymal Stem Cell Migration and Tissue Repair

2019 746 citations Xiaorong Fu et al. profile →
Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver

2015 329 citations Santhosh Satapati, Blanka Kucejová et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaorong Fu United States	26	1.6k	1.1k	886	676	553	59	3.7k
Y. Eugene Chen United States	39	2.6k 1.6×	918 0.8×	643 0.7×	341 0.5×	861 1.6×	143	5.0k
Manuel Morales‐Ruiz Spain	40	2.0k 1.2×	1.2k 1.1×	691 0.8×	431 0.6×	1.0k 1.9×	150	6.1k
Shaohua Wang China	40	2.3k 1.5×	363 0.3×	645 0.7×	329 0.5×	1.0k 1.9×	175	5.6k
Hideyuki Yamawaki Japan	43	2.2k 1.4×	1.2k 1.1×	1.2k 1.4×	253 0.4×	681 1.2×	169	5.8k
Sonja Hartwig Germany	31	1.1k 0.7×	854 0.8×	896 1.0×	489 0.7×	574 1.0×	91	3.2k
Gang Zheng China	40	2.4k 1.5×	565 0.5×	690 0.8×	224 0.3×	569 1.0×	206	5.6k
Takako Fujiwara Japan	43	2.5k 1.6×	896 0.8×	455 0.5×	219 0.3×	1.3k 2.4×	169	6.4k
Guoqiang Jiang China	33	2.5k 1.6×	458 0.4×	580 0.7×	1.1k 1.7×	1.3k 2.4×	87	4.8k
Mi‐Hye Lee South Korea	42	3.6k 2.3×	456 0.4×	279 0.3×	384 0.6×	1.3k 2.4×	131	6.1k
Yulin Li China	44	3.3k 2.1×	738 0.7×	520 0.6×	218 0.3×	845 1.5×	220	7.0k

Countries citing papers authored by Xiaorong Fu

Since Specialization

Citations

This map shows the geographic impact of Xiaorong Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaorong Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaorong Fu more than expected).

Fields of papers citing papers by Xiaorong Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaorong Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaorong Fu. The network helps show where Xiaorong Fu may publish in the future.

Co-authorship network of co-authors of Xiaorong Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaorong Fu. A scholar is included among the top collaborators of Xiaorong Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaorong Fu. Xiaorong Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sharma, Gaurav, Stanisław Deja, Xiaorong Fu, et al.. (2025). Metabolic and transcriptomic insights into temperature controlled hypothermic preservation of human donor hearts. The Journal of Heart and Lung Transplantation. 44(8). 1276–1287.

Fu, Xiaorong, Nancy D. Ernst, Julie Allen, et al.. (2025). Aerobic Capacity and Exercise Mediate Protection Against Hepatic Steatosis via Enhanced Bile Acid Metabolism. Function. 6(3). 2 indexed citations

Morgan, Donald A., Xiaorong Fu, Melissa R. Iñigo, et al.. (2025). FGF21 reverses MASH through coordinated actions on the CNS and liver. Cell Metabolism. 37(7). 1515–1529.e6. 14 indexed citations

Deja, Stanisław, Justin A. Fletcher, Chai-Wan Kim, et al.. (2024). Hepatic malonyl-CoA synthesis restrains gluconeogenesis by suppressing fat oxidation, pyruvate carboxylation, and amino acid availability. Cell Metabolism. 36(5). 1088–1104.e12. 31 indexed citations

Fu, Xiaorong, et al.. (2024). Hepatic ketogenesis is not required for starvation adaptation in mice. Molecular Metabolism. 86. 101967–101967. 6 indexed citations

Fu, Xiaorong, Justin A. Fletcher, Stanisław Deja, et al.. (2023). Persistent fasting lipogenesis links impaired ketogenesis with citrate synthesis in humans with nonalcoholic fatty liver. Journal of Clinical Investigation. 133(9). 23 indexed citations

Zhao, Ran, Xiaorong Fu, Ning Lü, et al.. (2022). Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo. Acta Pharmaceutica Sinica B. 12(11). 4122–4137. 14 indexed citations

Deja, Stanisław, Blanka Kucejová, Xiaorong Fu, et al.. (2021). In Vivo Estimation of Ketogenesis Using Metabolic Flux Analysis—Technical Aspects and Model Interpretation. Metabolites. 11(5). 279–279. 12 indexed citations

Fu, Xiaorong, Stanisław Deja, Justin A. Fletcher, et al.. (2021). Measurement of lipogenic flux by deuterium resolved mass spectrometry. Nature Communications. 12(1). 3756–3756. 26 indexed citations

10.

Fu, Xiaorong, Ran Zhao, Goo Yoon, et al.. (2021). 3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase in vitro and in vivo. Frontiers in Cell and Developmental Biology. 9. 638174–638174. 11 indexed citations

11.

Fletcher, Justin A., Stanisław Deja, Santhosh Satapati, et al.. (2019). Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver. JCI Insight. 4(11). 135 indexed citations

12.

Deja, Stanisław, Xiaorong Fu, Justin A. Fletcher, et al.. (2019). Simultaneous tracers and a unified model of positional and mass isotopomers for quantification of metabolic flux in liver. Metabolic Engineering. 59. 1–14. 23 indexed citations

13.

Morgan, Donald A., Kamal Rahmouni, Junichiro Sonoda, et al.. (2017). FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia. Cell Metabolism. 26(5). 709–718.e3. 206 indexed citations

14.

Kim, Chai-Wan, Carol Addy, Jun Kusunoki, et al.. (2017). Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation. Cell Metabolism. 26(2). 394–406.e6. 314 indexed citations

15.

Kucejová, Blanka, João Duarte, Santhosh Satapati, et al.. (2016). Hepatic mTORC1 Opposes Impaired Insulin Action to Control Mitochondrial Metabolism in Obesity. Cell Reports. 16(2). 508–519. 32 indexed citations

16.

McCommis, Kyle S., Zhouji Chen, Xiaorong Fu, et al.. (2015). Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling. Cell Metabolism. 22(4). 682–694. 168 indexed citations

17.

Vigueira, Patrick A., Kyle S. McCommis, George G. Schweitzer, et al.. (2014). Mitochondrial Pyruvate Carrier 2 Hypomorphism in Mice Leads to Defects in Glucose-Stimulated Insulin Secretion. Cell Reports. 7(6). 2042–2053. 82 indexed citations

18.

Satapati, Santhosh, Nishanth E. Sunny, Blanka Kucejová, et al.. (2012). Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver. Journal of Lipid Research. 53(6). 1080–1092. 311 indexed citations

19.

Chambers, Kari T., Zhouji Chen, Peter A. Crawford, et al.. (2012). Liver-Specific PGC-1beta Deficiency Leads to Impaired Mitochondrial Function and Lipogenic Response to Fasting-Refeeding. PLoS ONE. 7(12). e52645–e52645. 28 indexed citations

20.

Huang, Dan, et al.. (2009). Improved synthesis of sucrose fatty acid monoesters under ultrasonic irradiation. Ultrasonics Sonochemistry. 17(2). 352–355. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact